Adam is CEO of Alleviant Medical, Inc., a company focused on the development of minimally-invasive therapies for heart failure patients. Previously, Adam was CEO and Co-Founder of TVA Medical, Inc. (acquired by BD), where they developed a less-invasive procedure for patients in kidney failure. Prior, Adam held various commercial and R&D roles at Coalescent Surgical (acquired by Medtronic), MedicalCV and Computer Motion (acquired by Intuitive Surgical). Adam also serves as a Board member /advisor at several medtech companies. He received his BSE Magna Cum Laude in Biomedical Engineering from Rensselaer Polytechnic Institute and his MSE in Bioengineering from the University of Washington. Adam lives in Austin, Texas.